Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms22062967 http://scihub22266oqcxt.onion/10.3390/ijms22062967 33803997!8001312!33803997     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Mol+Sci 2021 ; 22 (6): ä Nephropedia Template TP {{tp|p=33803997|t=2021. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis |pdf=|usr=}}{{33803997}} gab.com Text Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33803997 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and mortality across the world, with no current effective treatments available. Recent studies suggest the possibility of a cytokine storm associated with severe COVID-19, similar to the biochemical profile seen in hemophagocytic lymphohistiocytosis (HLH), raising the question of possible benefits that could be derived from targeted immunosuppression in severe COVID-19 patients. We reviewed the literature regarding the diagnosis and features of HLH, particularly secondary HLH, and aimed to identify gaps in the literature to truly clarify the existence of a COVID-19 associated HLH. Diagnostic criteria such as HScore or HLH-2004 may have suboptimal performance in identifying COVID-19 HLH-like presentations, and criteria such as soluble CD163, NK cell activity, or other novel biomarkers may be more useful in identifying this entity. Twit Text FOAVip Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33803997 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33803997 #FOAvip English Wikipedia <ref>{{Cite pmid|33803997}}</ref> Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis #MMPMID33803997 Chu R; van Eeden C; Suresh S; Sligl WI; Osman M; Cohen Tervaert JW Int J Mol Sci 2021[Mar]; 22 (6): ä PMID33803997show ga The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and mortality across the world, with no current effective treatments available. Recent studies suggest the possibility of a cytokine storm associated with severe COVID-19, similar to the biochemical profile seen in hemophagocytic lymphohistiocytosis (HLH), raising the question of possible benefits that could be derived from targeted immunosuppression in severe COVID-19 patients. We reviewed the literature regarding the diagnosis and features of HLH, particularly secondary HLH, and aimed to identify gaps in the literature to truly clarify the existence of a COVID-19 associated HLH. Diagnostic criteria such as HScore or HLH-2004 may have suboptimal performance in identifying COVID-19 HLH-like presentations, and criteria such as soluble CD163, NK cell activity, or other novel biomarkers may be more useful in identifying this entity. |Antigens, CD/metabolism[MESH] |Antigens, Differentiation, Myelomonocytic/metabolism[MESH] |COVID-19/*complications/*diagnosis[MESH] |Humans[MESH] |Killer Cells, Natural/metabolism[MESH] |Lymphohistiocytosis, Hemophagocytic/*diagnosis/*etiology[MESH] |Receptors, Cell Surface/metabolism[MESH] |Receptors, Interleukin-2/metabolism[MESH]Do COVID-19 Infections Result in a Different Form of Secondary Hemopha(epmc).pdf DeepDyve Pubget Overpricing